We are live on ! Find out more
PPC

Park Place Capital Portfolio holdings

AUM $629M
1-Year Est. Return 18.27%
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
+18.27%
3 Year Est. Return
+59.97%
5 Year Est. Return
10 Year Est. Return
AUM
$629M
AUM Growth
+$131M
Cap. Flow
+$77.3M
Cap. Flow %
12.28%
Top 10 Hldgs %
40.22%
Holding
1,128
New
279
Increased
247
Reduced
202
Closed
37

Sector Composition

Rank Sector Weight
1 Miscellaneous 65.2%
2 Technology 11.1%
3 Financials 6.41%
4 Industrials 3.88%
5 Healthcare 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETSY icon
826
Etsy
ETSY
$7.02B
$1.28K ﹤0.01%
17
BKR icon
827
Baker Hughes
BKR
$63B
$1.28K ﹤0.01%
23
ONON icon
828
On Holding
ONON
$9.35B
$1.27K ﹤0.01%
36
-49
-58% -$1.79K
LGND icon
829
Ligand Pharmaceuticals
LGND
$5.69B
$1.26K ﹤0.01%
4
DLB icon
830
Dolby
DLB
$5.8B
$1.26K ﹤0.01%
24
BLDR icon
831
Builders FirstSource
BLDR
$7.08B
$1.25K ﹤0.01%
14
+1
+8% +$80
KNX icon
832
Knight Transportation
KNX
$11.7B
$1.17K ﹤0.01%
15
KVUE icon
833
Kenvue
KVUE
$36B
$1.15K ﹤0.01%
60
BBD icon
834
Banco Bradesco
BBD
$36.7B
$1.13K ﹤0.01%
326
BBIO icon
835
BridgeBio Pharma
BBIO
$14.6B
$1.12K ﹤0.01%
15
+7
+88% +$490
AM icon
836
Antero Midstream
AM
$10.7B
$1.11K ﹤0.01%
49
DORM icon
837
Dorman Products
DORM
$3.9B
$1.09K ﹤0.01%
8
SMCI icon
838
Super Micro Computer
SMCI
$26B
$1.08K ﹤0.01%
37
ASND icon
839
Ascendis Pharma A/S
ASND
$17.7B
$1.07K ﹤0.01%
+4
New +$934
DYN icon
840
Dyne Therapeutics
DYN
$4.53B
$1.04K ﹤0.01%
47
LRN icon
841
Stride
LRN
$3.52B
$1.03K ﹤0.01%
12
LEN.B icon
842
Lennar Class B
LEN.B
$19.8B
$976 ﹤0.01%
11
COGT icon
843
Cogent Biosciences
COGT
$6.03B
$968 ﹤0.01%
25
XENE icon
844
Xenon Pharmaceuticals
XENE
$5.79B
$966 ﹤0.01%
16
APPF icon
845
AppFolio
APPF
$7.59B
$962 ﹤0.01%
6
KVYO icon
846
Klaviyo
KVYO
$5.3B
$921 ﹤0.01%
61
+24
+65% +$398
HUBS icon
847
HubSpot
HUBS
$12.3B
$913 ﹤0.01%
5
-1
-17% -$209
PIPR icon
848
Piper Sandler
PIPR
$5.44B
$868 ﹤0.01%
12
PI icon
849
Impinj
PI
$5.27B
$859 ﹤0.01%
6
LYB icon
850
LyondellBasell Industries
LYB
$20.5B
$842 ﹤0.01%
16

Similar funds

Park Place Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Park Place Capital held 1,128 positions worth $629M, up 26% from $499M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Park Place Capital deployed $77.3M of net new capital in Q2 2026, opening 279 new positions and adding to 247 existing holdings. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 49,375 shares worth $4.97M.

By sector, the portfolio is most concentrated in Miscellaneous at 65% of assets, down from 67% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Broadridge, an estimated $1.43M trimmed.

  • Park Place Capital's largest Q2 2026 buy was iShares 0-3 Month Treasury Bond ETF: 49,375 shares worth $4.97M.
  • Park Place Capital added most to Broadcom in Q2 2026, an estimated $4.74M increase.
  • Park Place Capital's biggest Q2 2026 reduction was Broadridge, cutting an estimated $1.43M.
  • Park Place Capital fully exited Bank of Montreal in Q2 2026, selling an estimated $201K.
  • Park Place Capital's ten largest holdings make up 40% of its $629M portfolio in Q2 2026.
  • Park Place Capital opened 279 new positions and closed 37 in Q2 2026.
  • Park Place Capital's portfolio value rose 26% quarter-over-quarter to $629M.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.